Orthoproducts
Orthoproducts was an established provider (45% global market share) of high-quality, medical-grade ultra-high molecular weight polyethylene (UHMWPE) for hip, knee and spinal orthopaedic implants.
Harwood acquired the company through a divestment from a listed company and exited via a trade sale to a large medical device manufacturing and design company.
Fund
Fund 2
Investment date
April 2008
Deal type
Buyout
Sector
Health Services
Exit date
October 2013
Exit type
Trade sale